Close
Close
Treatment Database
(1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione
Trade Name not avaiable
Orphan Indication Systemic sclerosis
EU Market Approval
EU Designation Date 08-11-2017
Sponsor Quintiles Ireland Limited
More about Systemic scleroderma
Free Newsletter
Treatment News
Related Videos
by Birgit Bramlage
1,448 views
by Abidemi Uruejoma
7,862 views
by Abidemi Uruejoma
10,180 views
by Salima Mathews
9,312 views
by Salima Mathews
8,307 views